NPI 1346241395: Open Payments
NPI 1346241395. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 13 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $389 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $127 |
| Merck Sharp & Dohme LLC | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Boston Scientific Corporation | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Assure WCD, VERQUVO, LEQVIO, AREXVY, WATCHMAN, INSPIRE, Kerendia.
